Biotech | March 21, 2022
Wockhardt and Serum Life Sciences UK partner to manufacture multiple vaccines in UK
The facility will produce 150 million vaccine doses per year
The facility will produce 150 million vaccine doses per year
Since 1993, Beghou Consulting has helped life sciences companies - especially emerging pharmaceutical companies - establish and manage commercial operations to better market and sell therapies
Jointly fund and develop up to three antibody-drug conjugate programs for the treatment of cancer
Amit Jaju, Senior Managing Director, India in an interview with Thomas C Thottathil outlined the steps Indian pharma companies should follow to be compliant with global regulatory requirements
Despite advances over the past 20 years, ovarian cancer treatment requires better standard of care
Company to manufacture drug substance for clinical supply of HaemaLogiX’s lead multiple myeloma drug candidate, KappaMab, at its new state-of-the-art facility in Guangzhou, China
The new centre will comprise a team of 50 highly experienced specialists
SOLOSEC is designed to be easy to take and one oral dose contains a complete course of treatment
Entos will receive an initial payment of US $50 million, which includes an equity investment by Lilly
The company will collaborate with U.S.-based colleagues to help life sciences companies improve commercial effectiveness
Subscribe To Our Newsletter & Stay Updated
